Bionovate Technologies Corp
Bionovate Technologies Corp (BIIO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
biio · pe ratio · data through Jun 30, 2021
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bionovate Technologies Corp (BIIO) measures how much investors pay for each dollar of the company's trailing earnings. BIIO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2021-06-30
PE Ratio History
2011 – 2021 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bionovate Technologies CorpYou BIIO | $0M | N/A | — | -$0.01 |
 HLK Biotech Holding Group, Inc. AMHD | $0M | N/A | — | — |
 Adhera Therapeutics, Inc. ATRX | $0M | N/A | — | -$0.92 |
 BioELife Corp. LITH | $0M | N/A | — | -$0.13 |
 Micro Imaging Technology, Inc. MMTC | $0M | N/A | — | -$0.18 |
 Motus GI Holdings, Inc. MOTS | $0M | N/A | — | -$15.89 |
 Ontrak, Inc. OTRKQ | $0M | N/A | — | -$5.49 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2021-06-30Latest FY2021 | — | $-0.01 | — | |
2020-06-30 FY2020 | — | $-0.00 | — | |
2019-06-30 FY2019 | — | $-1.35 | — | |
2018-06-30 FY2018 | — | $-27.63 | — | |
2017-06-30 FY2017 | — | $0.00 | — | |
2016-06-30 FY2016 | — | $0.00 | — | |
2015-06-30 FY2015 | — | $0.00 | — | |
2014-06-30 FY2014 | — | $0.00 | — | |
2013-06-30 FY2013 | — | $0.00 | — | |
2012-06-30 FY2012 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bionovate Technologies Corp (BIIO) measures how much investors pay for each dollar of the company's trailing earnings. BIIO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.
Frequently asked questions
BIIO pe ratio · 6 questionsBIIO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via BIIO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bionovate Technologies Corp SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09